[S2 guideline for infectious endocarditis].
Microbe-induced (infectious) endocarditis is an endovascular infection, caused mainly by bacteria, of cardiovascular structures. The major predilection site are the native heart valves, but involvement of implanted intracardiac foreign material is increasingly being seen. The mortality rate of infectious endocarditis depends on clinical factors and the causal agent, but also on the time of the establishment of the diagnosis and the initiation of appropriate treatment. In Germany, the current mortality rate ranges up to 18%. Between January 2003 and July 2004, with the aim of improving patient care and thus the outcome of this condition, a guideline commission worked out recommendations for the diagnosis, treatment and management of the disease for the use of general practitioners and hospital physicians, in particular microbiologists, infectiologists, cardiologists and cardiac surgeons. The basis for this guideline was the systematic search through the literature of the European guideline. On the 16th and 28th of June 2004, the entire guideline was formerly approved in a nominal group process.
Naber
C K
CK
Klinik für Kardiologie, Universitätsklinikum Essen.
Bauhofer
A
A
Block
M
M
Buerke
M
M
Erbel
R
R
Graninger
W
W
Herrmann
M
M
Horstkotte
D
D
Kern
P
P
Lode
H
H
Mehlhorn
U
U
Meyer
J
J
Mügge
A
A
Niebel
J
J
Peters
G
G
Shah
P M
PM
Werdan
K
K
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001431:Bacteriological Techniques; D003937:Diagnosis, Differential; D004452:Echocardiography; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality / Q000601:surgery; D005194:Family Practice; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity
D000900:Anti-Bacterial Agents